首页 | 本学科首页   官方微博 | 高级检索  
     


HIGH AFFINITY BINDING SITES FOR [(3) H]SUBSTANCE P IN URINARY BLADDERS OF CATS WITH INTERSTITIAL CYSTITIS
Affiliation:1. School of Medicine, Department of Pharmacology, Keio University, 35 Shinanomachi, Shinjuku-ku, Kanto, Tokyo 160-8582, Japan;2. Keio Advanced Research Center for Water Biology and Medicine, Keio University, 2-15-45, Mita, Minato, Kanto, Tokyo 108-8345, Japan;3. Department of Agricultural Engineering and socio-Economics, Kobe University, 1-1 Rokkodai, Nada-ku, Kobe 657-8501, Kansai, Japan;1. Dynamics & Control Department, Ideko, Elgoibar, Basque Country, Spain;2. Precision Controls Laboratory (PCL), University of Waterloo, Waterloo, ON, Canada
Abstract:PurposePain is a common feature of interstitial cystitis (IC). Although the effects of IC on sensory neuron density have been investigated, its influence on substance P receptor (SPR) numbers and function are not well known. To evaluate the role of SPR in cats with IC, we measured the affinity (Kd), numbers (Bmax), and substrate specificity of binding sites for [(3) H]SP in urinary bladders of healthy cats and cats suffering from IC.Materials & MethodsRadioligand binding assays of cat and rat brain, normal cat bladders, and inflamed bladders from cats diagnosed with IC were conducted using [(3) H]SP to determine SPR affinity and numbers. Binding sites for [(125) I]SP were identified using autoradiography in slide-mounted frozen tissue sections, and their specificity determined with competition binding studies.ResultsIn bladder homogenate binding studies, low affinity SP binding sites for [(3) H]SP were found both in normal and inflamed tissue, whereas high affinity binding sites were found in inflamed bladder tissue only. Based on autoradiographic studies, high affinity binding appeared to be to small blood vessels, and to be specific for substance P, a pharmacology consistent with the neurokinin-1 receptor (NK1 R).ConclusionsUpregulation of NK1 R may be part of the pathophysiology of IC, as it is in some other inflammatory diseases. If so, more specifically targeted therapies for IC may become available.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号